Showing results (91-100 of 7,567) with videos related to
Sort By:
Pageof 757
Statistical Methods in Medical Research|April 8, 2004
Endpoints in vaccine trialsMichael G Hudgens, Peter B Gilbert, Steven G SelfStatistics in Biosciences|August 8, 2017
Estimation of Stratified Mark-Specific Proportional Hazards Models under Two-Phase Sampling with Application to HIV Vaccine Efficacy TrialsGuangren Yang, Yanqing Sun, Li Qi, et al.Journal of Virology|December 19, 2008
Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivoW David Wick, Peter B Gilbert, Otto O YangThe Journal of Infectious Diseases|December 2, 2017
Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin AmericaZoe Moodie, Michal Juraska, Ying Huang, et al.Biometrics|August 22, 2006
Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trialsBryan E Shepherd, Peter B Gilbert, Yannis Jemiai, et al.Journal of the Royal Statistical Society. Series B, Statistical Methodology|March 16, 2010
Semiparametric estimation of treatment effects given base-line covariates on an outcome measured after a post-randomization event occursYannis Jemiai, Andrea Rotnitzky, Bryan E Shepherd, et al.Biometrics|October 12, 2020
Nonparametric variable importance assessment using machine learning techniquesBrian D Williamson, Peter B Gilbert, Marco Carone, et al.Computational Statistics & Data Analysis|June 13, 2018
Analysis of Generalized Semiparametric Regression Models for Cumulative Incidence Functions with Missing CovariatesUnkyung Lee, Yanqing Sun, Thomas H Scheike, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rateDonald N Forthal, Peter B Gilbert, Gary Landucci, et al.Vaccine|November 22, 2008
Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trialsPeter B Gilbert, Alicia Sato, Xiao Sun, et al.Pageof 757